Close Menu
    Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Antimicrobial Resistance

    Anthrax Genome Research Reveals Novel Targets

    By Global Biodefense StaffAugust 21, 2012
    Share
    Facebook LinkedIn Reddit Email

    Researchers at Acharya Nagarjuna University in India have carried out a search of the Bacillus anthracis bacterial genome, revealing a clutch of targets for new drugs to combat an epidemic of anthrax or a biological weapons attack.

    The study, conducted in collaboration with the Osmanaia University College for Women, identified 270 non-redundant, non-human homologous genes and 103 essential genes of the bacteria as possible drug targets. Each are proteins that are found in the bacteria but not in humans and are involved in diverse bacterial processes such as metabolism, cell wall synthesis and bacterial persistence.

    The researchers identified sixteen membrane-bound proteins, seven proteases and three adhesion molecules that are all novel. The discovery of a range of targets might bode well for creating a drug cocktail that could preclude the emergence of drug resistance.

    Early diagnosis and treatment with potent antibiotics is essential in any of the three clinical forms of anthrax: cutaneous, gastrointestinal and pulmonary. Unfortunately, the bacteria have evolved resistance to common antibiotics including ciprofloxacin, doxycycline and beta-lactam type drugs. The team now hopes that its identification of a range of novel targets for antibiotics will allow medicinal chemists to quickly screen for activity among diverse molecules as putative antibiotics.

    Results of the research titled “Genome wide search for identification of potential drug targets in Bacillus anthracis” were recently published in the International Journal of Computational Biology and Drug Design.

    Anthrax Bioterrorism
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleDetector Uses Sound Waves to Identify Chemical Agent Attacks
    Next Article Military CBRNE Support Contract Draft RFP Released

    Related Stories

    First Light Diagnostics Receives FDA Clearance for Rapid Anthrax Test

    December 5, 2023

    Needle-Free Vaccine Patch Against Zika Virus

    December 2, 2023

    Inflammatix Completes Development for Acute Infection and Sepsis Test System

    November 15, 2023

    NanoViricides’ Phase 1 Broad-Spectrum Antiviral Highly Effective for Mpox and Smallpox

    November 14, 2023
    News Scan

    Biodefense Headlines – 30 November 2023

    News Scan November 30, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include the largest ever outbreak of mpox in the DRC; launch of National Wastewater Surveillance Program dashboard; low uptake of COVID-19 boosters and flu vaccines;…

    Upcoming Events

    Dec 5
    10:45 am - 3:00 pm EST

    Meeting the Moment: Biodefense Policy, Procurement, and Public Health

    Dec 6
    Virtual Event Virtual Event
    6:00 am - 7:00 am EST

    AMR One Health Priority Research Agenda: Transmission

    Mar 12
    Virtual Event Hybrid Event
    March 12, 2024 - March 17, 2024

    2024 Fungal Genetics Conference

    Mar 21
    March 21, 2024 - March 23, 2024

    ASPPH 2024 Annual Meeting

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    News on pathogens and preparedness for public health emergencies

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.